조류 인플루엔자 백신 시장 규모, 점유율, 성장 분석 : 백신 유형별, 용도별, 주식별, 투여 경로별, 대상 유형별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Avian Influenza Vaccine Market size was valued at USD 152.01 Billion in 2024 and is poised to grow from USD 158.39 Billion in 2025 to USD 220.13 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

Global insights into the avian influenza vaccine market reveal significant concerns surrounding the avian influenza virus type A, primarily affecting domestic poultry and originating from waterfowl. Notably, various subtypes such as H5N1, H7N3, H7N9, and H9N2 have emerged, with H5N1 recognized as the most pathogenic. The transmission potential to humans highlights the urgency of effective vaccine development. The avian influenza vaccine classification includes H5, H7, and H9 vaccines, catering to different strains. China has established itself as a major manufacturer, while the U.S. follows closely. As global awareness of avian influenza grows, the demand for vaccines targeting these specific strains is anticipated to rise, promoting further investment and innovation in vaccine development to mitigate associated health risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Avian Influenza Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Avian Influenza Vaccine Market Segments Analysis

Global Avian Influenza Vaccine Market is segmented by Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines, Recombinant Vaccines and Subunit Vaccines. Based on Application, the market is segmented into Chicken, Duck and Goose, Turkey and Others. Based on Strain, the market is segmented into H5 Strain, H7 Strain and H9 Strain. Based on Administration Route, the market is segmented into Intramuscular, Subcutaneous and Waterborne. Based on Target Species, the market is segmented into Broilers, Layers, Breeders and Backyard Poultry. Based on Distribution Channel, the market is segmented into Veterinary Clinics, Online Pharmacies and Retail Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Avian Influenza Vaccine Market

The global market for avian influenza vaccines is primarily driven by the prevalence and impact of the avian influenza virus, particularly type A, which is frequently found in waterfowl and can infect domestic poultry like chickens. This virus is categorized into various subtypes based on its surface proteins, namely hemagglutinin and neuraminidase, which play a role in its classification as either highly pathogenic or low pathogenic. While nonpathogenic variants may lead to mild symptoms, highly pathogenic strains can result in significant mortality rates in poultry, necessitating effective vaccination strategies to protect bird populations and mitigate economic losses in the poultry industry.

Restraints in the Global Avian Influenza Vaccine Market

A significant challenge in the Global Avian Influenza Vaccine market arises from the swift mutation rate of the avian influenza virus, which hampers efforts to sustain effective vaccine coverage. This constant evolution of the virus necessitates ongoing research to gain a deeper understanding of its dynamics, paving the way for enhancements in vaccine formulations. The need to adapt vaccines to address these mutations poses a restraint on the market, as it demands continuous innovation and investment to ensure that immunization efforts remain relevant and effective in combating this ever-changing pathogen.

Market Trends of the Global Avian Influenza Vaccine Market

The Global Avian Influenza Vaccine market is witnessing a significant upward trend, particularly in the Asia-Pacific region, driven by the prevalence of bird flu viruses in key countries such as Israel, China, India, and South Korea. Enhanced supply chain efficiencies facilitate faster vaccine distribution, while robust research and development infrastructures, supported by favorable government policies, are accelerating innovation in vaccine technology. Increased awareness about the economic and health impacts of avian influenza is further propelling demand for effective vaccination solutions. As a result, stakeholders are actively investing in advanced vaccine developments, positioning themselves for growth in this critical market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Avian Influenza Vaccine Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Inactivated Vaccines
• Live Recombinant Vaccines
• Combination Vaccines
• Recombinant Vaccines
• Subunit Vaccines

Global Avian Influenza Vaccine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chicken
• Duck and Goose
• Turkey
• Others

Global Avian Influenza Vaccine Market Size by Strain & CAGR (2026-2033)

• Market Overview
• H5 Strain
• H7 Strain
• H9 Strain

Global Avian Influenza Vaccine Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Intramuscular
• Subcutaneous
• Waterborne

Global Avian Influenza Vaccine Market Size by Target Species & CAGR (2026-2033)

• Market Overview
• Broilers
• Layers
• Breeders
• Backyard Poultry

Global Avian Influenza Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Online Pharmacies
• Retail Stores

Global Avian Influenza Vaccine Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxart, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinovac Biotech Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seqirus UK Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations